Jefferies Group LLC Global Blood Therapeutics, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Global Blood Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 46,344 shares of GBT stock, worth $0. This represents 0.03% of its overall portfolio holdings.

Number of Shares

46,344

Holding current value

% of portfolio

0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$32.4 - $68.18 $1.05 Million - $2.21 Million	32,446 Added 233.46%	46,344 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $4.19 Million - $8.81 Million	129,246 Added 841.23%	144,610 $9.47 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $32,691 - $54,813	1,466 Added 10.55%	15,364 $491,000
Q1 2022 Sep 21, 2023	SELL	$25.68 - $35.59 $285,099 - $395,120	-11,102 Reduced 44.41%	13,898 $481,000
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $153,925 - $213,326	-5,994 Reduced 30.13%	13,898 $481,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $127,189 - $205,648	-5,108 Reduced 20.43%	19,892 $582,000
Q3 2021 Sep 21, 2023	BUY	$25.48 - $37.34 $497,012 - $728,354	19,506 Added 355.04%	25,000 $637,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $497,012 - $728,354	19,506 Added 355.04%	25,000 $637,000
Q2 2021 Sep 21, 2023	SELL	$32.46 - $43.42 $4.52 Million - $6.04 Million	-139,116 Reduced 96.2%	5,494 $192,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $178,335 - $238,549	5,494 New	5,494 $192,000
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $841,515 - $1.43 Million	-22,351 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $3.73 Million - $5.27 Million	-70,736 Reduced 75.99%	22,351 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $1.22 Million - $2.05 Million	25,049 Added 36.82%	93,087 $5.88 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $2.84 Million - $5.93 Million	67,971 Added 101449.25%	68,038 $3.48 Million
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $1 Million - $1.8 Million	-21,933 Reduced 99.7%	67 $5,000
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $536,944 - $685,654	11,840 Added 116.54%	22,000 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $378,562 - $455,498	-7,197 Reduced 41.46%	10,160 $534,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $124,583 - $184,346	-3,950 Reduced 18.54%	17,357 $713,000
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $809,666 - $1.09 Million	21,307 New	21,307 $810,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account